Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic magnesium to decrease the arrhythmogenic potential of class III antiarrhythmic agents in a rabbit model.

C M White1, J Xie, M S Chow

  • 1University of Connecticut School of Pharmacy, Storrs, USA.

Pharmacotherapy
|May 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analytical performance and potential clinical utility of the GenMark Dx ePlex® blood culture identification gram-positive panel.

Diagnostic microbiology and infectious disease·2022
Same author

Salvaging the dehisced glans penis.

Journal of pediatric urology·2018
Same author

The influence of resting blood pressure on muscle strength in healthy adults.

Blood pressure monitoring·2018
Same author

Molecular fingerprinting of principal neurons in the rodent hippocampus: A neuroinformatics approach.

Journal of pharmaceutical and biomedical analysis·2017
Same author

Breeding population fluctuations in some raptors.

Oecologia·2017
Same author

Fluctuations of observed breeding Rough-legged Hawks and Gyrfalcons: regularity reconsidered.

Oecologia·2017
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
Same journal

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same journal

Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients.

Pharmacotherapy·2026
See all related articles

Intravenous magnesium sulfate reduced torsades de pointes and early after-depolarizations in a rabbit model. Magnesium effectively decreased arrhythmia occurrence without altering the QT interval, suggesting a potential prophylactic role.

Area of Science:

  • Cardiology
  • Pharmacology
  • Electrophysiology

Background:

  • Torsades de pointes (TdP) is a life-threatening ventricular arrhythmia.
  • Early after-depolarizations (EADs) are implicated in the pathogenesis of TdP.
  • Magnesium is known to affect cardiac electrophysiology.

Purpose of the Study:

  • To evaluate the prophylactic effect of intravenous magnesium sulfate on TdP and EADs.
  • To assess the impact of magnesium sulfate on the QT interval (QTc).
  • To investigate magnesium's role in a rabbit model of drug-induced arrhythmias.

Main Methods:

  • Ten rabbits were administered methoxamine to induce bradycardia.
  • Five rabbits received magnesium sulfate (bolus and infusion).
  • Five rabbits received normal saline concurrently with clofilium, a Class III antiarrhythmic agent.

Related Experiment Videos

  • Electrocardiogram (ECG) and monophasic action potentials were recorded.

    • Main Results:

    • The magnesium group showed significantly fewer instances of TdP and EADs compared to the saline group (p=0.048).
    • No significant differences in QT or QTc intervals were observed between the magnesium and saline groups.
    • Magnesium administration decreased TdP and EAD occurrence without affecting QTc prolongation.

    Conclusions:

    • Intravenous magnesium sulfate demonstrates a prophylactic effect against TdP and EADs in this rabbit model.
    • Magnesium's antiarrhythmic benefit appears independent of significant QT/QTc interval modification.
    • Further human studies are warranted to validate these findings in clinical settings.